Product Catalog
Generic Ampicillin (Generic Ampicillin, Ampicillin® equivalent)
Ampicillin is a Broad-spectrum antibiotic in the class of medications called penicillins. Ampicillin fights bacteria in your body. Ampicillin is used to treat many different types of infections, such as tonsillitis, pneumonia, bronchitis, urinary tract infections, gonorrhea, and infections of the intestines such as salmonella (food poisoning). Ampicillin may also be used for purposes other than those listed in this medication guide. If you are allergic to penicillin do not order this medication.
This product will arrive to you in 14-24 business days (free shipping worldwide)
500mg
| Quantity | Price | Price per pill | Returning customer price | Bonus | |
|---|---|---|---|---|---|
| 10 | $ 47.00 | $ 4.70 | $ 42.00 | ---- | Add to cart |
| 20 | $ 53.00 | $ 2.65 | $ 47.00 | ---- | Add to cart |
| 30 | $ 60.00 | $ 2.00 | $ 54.00 | ---- | Add to cart |
Drug Medical Information
CHELATION THERAPY: BOOKS ARE NOT WINE -THEY DO NOT IMPROVE WITH AGE – HOPES FOR ESTABLISHMENT ACCEPTANCE OF CHELATION AND OTHER ALTERNATE THERAPIES HAVE TAKEN A NEW TURN & THE MUCH-HERALDED FDA STUDY OF EDTA WILL NOT BE COMPLETED AS PROMISED
Hopes for establishment acceptance of chelation and other alternate therapies have taken a new turn. The growth of public enthusiasm for non-invasive treatments has triggered a backlash, intensifying opposition against all natural remedies. One state (Arizona) recently 'outlawed' chelation. Clinicians who challenge orthodoxy routinely face persecution and prosecution, making it more evident than ever that scientific investigation on its own is not likely to set the record straight. Clearly there's a need for consumers, educated as to what's at stake, to work together to protect chelation and other benign therapies from extinction. The much-heralded FDA study of EDTA will NOT be completed as promised. The 'Chelation Project' seeking FDA approval of EDTA for arterial disease via controlled double blind clinical trials, begun with such optimism in 1985, has stalled time and again and is now defunct. Contrary to information published in the 'updated second edition' of Bypassing Bypass, that study is over.
*4\297\8*
